Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634855 · ClinicalTrials.gov registry record
Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR
A clinical trial, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- 11
- Enrollment target
NCT00634855: Clinical Trial study, sponsored by Medical University of South Carolina.
NCT00634855 is a clinical trial that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634855 was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether there are alterations in the population of endothelial progenitor cells in umbilical cord blood samples of infants born in the setting of maternal preeclampsia or fetal growth restriction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-03 |
Why NCT00634855 stopped before completion
NCT00634855 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00634855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00634855 about?
NCT00634855 is a clinical study titled "Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR". The objective of this study is to determine whether there are alterations in the population of endothelial progenitor cells in umbilical cord blood samples of infants born in the setting of maternal preeclampsia or fetal growth restriction.
What is the current status of trial NCT00634855?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2008-03. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00634855?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia